USD 5.21 billion
North America Stem Cell Market Size, Share, Growth Analysis, By Product Type(Adult Stem Cell, Human Embryonic Stem Cell, and Pluripotent), By Application(Orthopaedic Treatments, Injuries & Wounds, Oncology Disorders, Cardiovascular Disorders), By Treatment(Allogeneic Stem Cell Therapy, Autologic Stem Cell Therapy, and Syngeneic Stem Cell Therapy), By Region - Industry Forecast 2024-2031
Report ID:
SQMIG35D2103 |
Region:
Global |
Published Date: February, 2024
Pages:
157
|Tables:
93
|Figures:
76
North America Stem Cell Market Insights
North America Stem Cell Market size was valued at USD 5.68 billion in 2022 and is poised to grow from USD 6.19 billion in 2023 to USD 12.36 billion by 2031, growing at a CAGR of 9.02% in the forecast period (2024-2031).
The North America stem cell market is a rapidly growing and evolving sector that holds great promise for medical advancements and therapeutic applications. This growth can be attributed to various factors, including the rise in public-private funding and investments dedicated to stem cell research. Furthermore, the growth of the market has been fueled by advancements in stem cell manufacturing and preservation technologies. These advancements have played a crucial role in expanding the market for stem cell therapy, transplant, and research. Additionally, increased public awareness of the therapeutic potential of stem cell products has contributed to the market's upward trajectory. However, it is important to acknowledge the challenges that may arise from unapproved stem cell interventions and regulatory issues surrounding the therapeutic application of stem cells. These factors require careful consideration to ensure the ethical and safe development of the stem cell industry in North America. Moreover, the market expansion is supported by rising investments in stem cell-based therapies and favorable government regulations and policies. North America benefits from a well-established infrastructure for stem cell banking, facilitating the storage and utilization of stem cells for both research and clinical purposes. Notably, the region has witnessed significant progress in stem cell therapies for knee-related conditions, with advancements in stem cell injection and treatment techniques specifically targeted for knee ailments. Additionally, the collaboration between academia, industry, and healthcare providers has further propelled the growth of the market. This collaborative effort has enabled key players in the pharmaceutical and biotechnology sectors to recognize the immense potential of stem cell therapies, leading to substantial investments in research and development initiatives. The synergistic partnerships fostered by these collaborations have been instrumental in driving the expansion of the stem cell industry in North America.
Market Snapshot - 2024-2031
Global Market Size
Largest Segment
Adult Stem Cell
Fastest Growth
Adult Stem Cell
Growth Rate
9.02% CAGR
North America Stem Cell Market ($ Bn)
Country Share for North America Region (%)
To get more reports on the above market click here to Buy The Report
North America Stem Cell Market Segmental Analysis
The North America Stem Cell Market is segmented by product type, application, treatmen,t and region. Based on product type, the market can be segmented into adult stem cell, human embryonic stem cell, and pluripotent. Based on application, the market is segmented into orthopaedic treatments, injuries & wounds, oncology disorders, cardiovascular disorders, neurological disorders, and diabetes. Based on treatment, the market is segmented into allogeneic stem cell therapy, autologic stem cell therapy, and syngeneic stem cell therapy. Based on region, the market is segmented into US, Canada, Mexico, and Rest of North America.
North America Stem Cell Market Analysis by Product type
By product type, the market can be segmented into adult stem cell, human embryonic stem cell, and pluripotent. The adult stem cell segment currently dominates the North American stem cell market. Adult stem cells are found in various tissues and organs of the body and have the ability to differentiate into specialized cell types. They are typically obtained from sources such as bone marrow, adipose tissue, and blood. Adult stem cells have shown significant potential in regenerative medicine and tissue engineering applications. They are being used in the treatment of various diseases and conditions, including cardiovascular disorders, orthopaedic injuries, and neurological disorders.
The pluripotent stem cell segment is the fastest growing segment in the North American stem cell market. Pluripotent stem cells have the remarkable ability to differentiate into any cell type in the body. They can be derived from various sources, including human embryos and induced pluripotent stem cells (iPSCs) generated through cellular reprogramming. Pluripotent stem cells offer exciting prospects for personalized medicine. iPSCs can be generated from a patient's own cells, allowing for the development of patient-specific cell therapies. This holds immense promise for the treatment of genetic disorders, as well as the advancement of precision medicine approaches.
Analysis by Application
By application, the market can be segmented into orthopaedic treatments, injuries & wounds, oncology disorders, cardiovascular disorders, neurological disorders, and diabetes. The oncology disorders segment currently dominates the North American stem cell market in terms of therapeutic application. Stem cell-based therapies have gained considerable attention and have shown promise in the field of oncology. Stem cells have the ability to self-renew and differentiate into different cell types, making them an attractive option for cancer treatment. They can be used in various ways, including as carriers for targeted drug delivery, as vehicles for gene therapy, or as a source of healthy cells for transplantation.
While the neurological disorders segment is the fastest growing segment in the North American stem cell market in terms of therapeutic application. Stem cell-based therapies hold significant potential for the treatment of various neurological disorders, including Parkinson's disease, Alzheimer's disease, spinal cord injuries, and stroke. Neurological disorders represent a significant healthcare burden, and effective treatments are limited. Stem cells offer the potential to replace damaged or lost neurons, regenerate neural circuits, and provide neuroprotective effects. The urgent unmet medical needs in neurological disorders drive the development and adoption of stem cell-based therapies, contributing to the segment's rapid growth.
North America Stem Cell Market By Product Type
To get detailed analysis on other segments, Request For Free Sample Report
North America Stem Cell Market Regional Insights
The United States dominated the North America stem cell market. The country's dominance can be attributed to several factors. Firstly, the United States has a robust healthcare infrastructure, including renowned research institutions and leading biotechnology companies. These entities drive significant research and development activities, contributing to the advancement of stem cell therapies. Moreover, the United States has favorable regulatory frameworks that support the development and commercialization of stem cell-based products. The Food and Drug Administration (FDA) has established guidelines for the clinical use of stem cells, ensuring safety and efficacy. This regulatory environment encourages investment and innovation, attracting both domestic and international stakeholders to the market.
Canada is emerging as the fastest growing region in the North America stem cell market. The country's growth can be attributed to several factors. Firstly, Canada has a well-developed healthcare system and world-class research institutions that actively contribute to stem cell research and development. These institutions collaborate with industry partners to drive innovation and translate scientific discoveries into clinical applications. Moreover, Canada has implemented supportive government policies and funding initiatives that promote stem cell research and regenerative medicine. The Canadian Institutes of Health Research (CIHR) and other funding bodies provide grants and resources to support stem cell-related projects, fostering a favorable environment for growth and innovation.
North America Stem Cell Market By Geography
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
North America Stem Cell Market Dynamics
North America Stem Cell Market Drivers
Increasing prevalence of chronic diseases and age-related conditions
- One significant driver propelling the growth of the North America stem cell market is the increasing prevalence of chronic diseases and age-related conditions. Chronic diseases such as cardiovascular disorders, diabetes, and neurodegenerative diseases pose significant healthcare challenges in the region. Stem cell therapies offer the potential to address these conditions by regenerating damaged tissues and replacing dysfunctional cells. The rising burden of these diseases, coupled with the limitations of existing treatment options, has created a strong demand for innovative therapies. This demand is driving research, investment, and development in the field of stem cell therapies, thus fueling the growth of the North America stem cell market.
North America Stem Cell Market Restraints
Ethical and regulatory considerations
- One notable restraint hindering the growth of the North America stem cell market is the ethical and regulatory considerations associated with stem cell research and therapies. The use of embryonic stem cells raises ethical concerns due to the destruction of embryos, leading to debates and restrictions on their usage in certain jurisdictions. Additionally, regulatory frameworks and approval processes for stem cell-based therapies can be stringent and time-consuming, resulting in delays in product development and commercialization. These ethical and regulatory challenges can create barriers to entry, limit funding opportunities, and impede the pace of advancements in the North America stem cell market.
Request Free Customization of this report to help us to meet your business objectives.
North America Stem Cell Market Competitive Landscape
North America stem cell market is characterized by a diverse range of companies, research institutions, and academic organizations actively engaged in stem cell research and development. Several players are focused on advancing stem cell technologies and translating scientific discoveries into therapeutic applications. These entities compete based on factors such as product portfolio, research capabilities, clinical trials, intellectual property, and strategic collaborations. The market also witnesses competition in terms of manufacturing capabilities, distribution networks, and regulatory compliance. With the field of stem cell research rapidly evolving, the competitive landscape is dynamic, with new entrants and collaborations shaping the market dynamics.
North America Stem Cell Market Top Player’s Company Profiles
- Mesoblast Ltd.
- ViaCyte, Inc.
- Fate Therapeutics, Inc.
- Celgene Corporation
- BlueRock Therapeutics
- Osiris Therapeutics, Inc.
- Athersys, Inc.
- Cynata Therapeutics Limited
- Gamida Cell Ltd.
- Astellas Pharma Inc.
- Novartis AG
- Gilead Sciences, Inc.
- Intrexon Corporation
- Vericel Corporation
- Organogenesis Inc.
- Caladrius Biosciences, Inc.
- Pluristem Therapeutics Inc.
North America Stem Cell Market Recent Developments
- In July 2022, CORESTEM (South Korea) continued enrolling participants for the Phase 3 clinical trial of NeuroNata-R, a stem cell therapy that is conditionally approved to treat amyotrophic lateral sclerosis (ALS) in South Korea.
- In May 2022, ViaCyte, Inc. partnered with SQZ Biotechnologies to develop and commercialize the search-use-only (RUO) microfluidic intracellular delivery system. The partnership will allow both the market players to present new cell engineering data in hematopoietic stem cells using mRNA
- In March 2022, MEDIPOST had invested in a contract development and manufacturing company (CDMO) for cell gene therapy products in North America and clinical trials in the U.S., such as stem cell therapy. CARTISTEM is a stem cell therapy procedure for the treatment of degenerative osteoarthritis
North America Stem Cell Key Market Trends
- Focus on personalized medicine and targeted therapies: One notable market trend in the North America stem cell market is the increasing focus on personalized medicine and targeted therapies. As stem cell research advances, there is a growing emphasis on tailoring treatments to individual patients based on their unique genetic makeup, disease characteristics, and regenerative needs. This trend is driven by advancements in technologies such as induced pluripotent stem cells (iPSCs) and gene editing techniques, which allow for the generation of patient-specific stem cells and the manipulation of their properties. The shift towards personalized stem cell therapies holds great potential for enhancing treatment efficacy, reducing side effects, and improving patient outcomes, thereby shaping the future of the North America stem cell market.
North America Stem Cell Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
According to our North America stem cell market analysis, the market is poised for a promising future, driven by the potential of stem cell therapies to revolutionize healthcare. With ongoing advancements in research, technology, and regulatory frameworks, the market holds significant growth opportunities. Personalized medicine and targeted therapies are emerging as a prominent trend, allowing for tailored treatments based on individual patient needs. While the United States remains the dominating country in the region, Canada is experiencing rapid growth as a key player. The largest segment in the market encompasses regenerative medicine and tissue engineering applications, fueled by the increasing prevalence of chronic diseases and age-related conditions. Additionally, the fastest growing segment lies in the development of induced pluripotent stem cells (iPSCs) and gene editing techniques, unlocking new possibilities for customized treatments. These factors collectively indicate a promising future for the market.
| Report Metric | Details |
|---|---|
| Market size value in 2022 | USD 5.68 billion |
| Market size value in 2031 | USD 12.36 billion |
| Growth Rate | 9.02% |
| Base year | 2023 |
| Forecast period | 2024-2031 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on North America Stem Cell Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on North America Stem Cell Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the North America Stem Cell Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the North America Stem Cell Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the North America Stem Cell Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the North America Stem Cell Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
USA (+1) 351-333-4748
